COUNTERFEIT AND ILLEGAL MEDICINAL PRODUCTS AS AN EXAMPLE OF DRUGS THAT DO NOT MEET THE BASIC QUAITY REQUIREMENTS

Author:

Kalicka Agnieszka,Tarłowska Natalia

Abstract

Falsification or counterfeiting of medicinal products is a severe pharmaceutical crime. According to the World Health Organization, about 10% of medicinal products in developing countries are falsified. In the case of medicines sold over the Internet, the figure is as high as 50%, and this phenomenon's scale is increasing yearly. The illegally sourced preparations are not manufactured in accordance with Good Manufacturing Practice (GMP). Among the most frequently falsified medicinal products are preparations used for erectile dysfunction, weight loss aids, or anabolic-androgenic steroids. The presence of undeclared active ingredients and impurities, incorrect dosage due to different than declared contents, and the sourcing of over-the-counter medicines from unknown sources can lead to serious side effects that threaten patients' lives and health. In addition, inaccurate or incomplete descriptions of product formulation can additionally cause the risk of drug interactions, which can consequently lead to serious medical incidents. The purpose of this paper is to discuss the requirements for medicinal products and to present the problem of the quality of counterfeit and illegal medicinal products. This issue is discussed using phosphodiesterase type 5 inhibitors (applied to the treatment of erectile dysfunction) as an example. KEYWORDS: falsified medicinal products, quality of medicinal products, PDE-5 inhibitors

Publisher

Warszawski Uniwersytet Medyczny

Reference76 articles.

1. Leciejewska-Ziemecka, E.; Pachecka, J., "Farmakopea Polska – od wymagań narodowych do zharmonizowanych", Farm. Pol., 2010, 66(5), 369-372. https://www.ptfarm.pl/pub/File/Farmacja%20Polska/2010/05-2010/12%20%20Farmakopea.pdf (data dostępu: 17-07-2023).

2. ICH Quality Guidelines. https://www.ich.org/page/quality-guidelines (data dostępu: 17-07-2023).

3. Farmakopea polska wydanie X, 2014

4. Bielawa, A. Postrzeganie i rozumienie jakości – przegląd definicji jakości. Studia i Prace Wydziału Nauk Ekonomicznych i Zarządzania. 2011, 21, 144-52. http://wneiz.pl/nauka_wneiz/sip/sip21-2011/SiP-21-11.pdf (data dostępu: 17-07-2023).

5. Ustawa z dnia 6 września 2001 r. Prawo farmaceutyczne. https://isap.sejm.gov.pl/isap.nsf/download.xsp/WDU20011261381/O/D20011381.pdf (data dostępu: 17-07-2023).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3